Abstract | SCOPE: Dietary isothiocyanates (ITCs) from cruciferous vegetables have shown potent anti- breast cancer activities in preclinical models, but their anticancer effects in vivo in breast cancer patients remain elusive. A proof-of-principle, presurgical window of opportunity trial is conducted to assess the anticancer effects of dietary ITCs in breast cancer patients. METHODS AND RESULTS: Thirty postmenopausal breast cancer patients are randomly assigned to receive ITC-rich broccoli sprout extract (BSE) (200 µmol ITC per day) or a placebo for 2 weeks. Expression of biomarkers related to ITCs functions are measured in breast cancer tissue specimens at pre- and post-interventions using immunohistochemistry staining. First morning urine samples are collected at both timepoints for proteomic analysis. Overall, the study shows high compliance (100%) and low toxicity (no grade 4 adverse event). Trends of increase in cleaved caspase 3 and tumor-infiltrating lymphocytes (TILs) and trends of decrease in Ki-67 and nuclear to cytoplasm ratio of estrogen receptor (ER)-α are observed in the BSE arm only, consistent with the significantly altered signaling pathways identified in urinary proteomic analysis. CONCLUSIONS: Anticancer activities of ITCs are observed in breast cancer patients, supporting the potential beneficial roles of ITC-containing cruciferous vegetables in breast cancer prognosis.
|
Authors | Zinian Wang, Chengjian Tu, Rachel Pratt, Thaer Khoury, Jun Qu, Jed W Fahey, Susan E McCann, Yuesheng Zhang, Yue Wu, Alan D Hutson, Christine B Ambrosone, Stephen B Edge, Helen H Cappuccino, Kazuaki Takabe, Jessica S Young, Li Tang |
Journal | Molecular nutrition & food research
(Mol Nutr Food Res)
Vol. 66
Issue 12
Pg. e2101094
(06 2022)
ISSN: 1613-4133 [Electronic] Germany |
PMID | 35475592
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural)
|
Copyright | © 2022 Wiley-VCH GmbH. |
Chemical References |
- Isothiocyanates
- Plant Extracts
|
Topics |
- Brassica
- Breast Neoplasms
(drug therapy)
- Female
- Humans
- Isothiocyanates
- Plant Extracts
(pharmacology)
- Proteomics
|